Stephen Saad's Aspen secures royalty-free rights to Merck's once-monthly HIV pill
Billionaires Africa | 25.07.2026 15:42
Aspen Pharmacare Holdings has secured royalty-free rights from Merck & Co. to manufacture and sell an experimental once-monthly HIV prevention pill across 129 low- and lower-middle-income countries, placing Africa's largest drugmaker in line to supply a medicine that has not yet cleared late-stage trials.
